Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Optic Nerve Glioma × Vincristine × Clear all

Phase

Status

Completed 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Burkitt Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 7 Lymphoma, B-Cell 6 Rhabdomyosarcoma 5 Neuroblastoma 5 Leukemia, Biphenotypic, Acute 5 Sarcoma, Ewing 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Wilms Tumor 2 Retinoblastoma 2 Recurrence 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Osteosarcoma 2 Medulloblastoma 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Pleuropulmonary blastoma 1 Pediatric Solid Tumor 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neoplasms 1

Interventions

Vincristine 1 Endostatins 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡